Bionano retires $20M convertible debentures, eliminates secured debt
Bionano Genomics fully retired all outstanding Senior Secured Convertible Debentures using cash on hand, eliminating all secured debt obligations and asset liens. The move removes financial constraints and provides greater operational flexibility for the company to focus on comme
View filing at SEC.gov →